Compare Cintas Corporation (CTAS) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cintas Corporation vs Stryker Corporation — how do they compare? Cintas Corporation trades at $202.61 (market cap $79.86B), while Stryker Corporation trades at $277.38 (market cap $106.24B). The key difference: Stryker Corporation is the larger of the two by market cap, and Stryker Corporation pays the higher dividend (1.27%). Which is the better fit depends on your goals — on Pluang, investors hold Cintas Corporation for 125 Days and Stryker Corporation for 21 Days on average.
| CTAS | SYK | |
|---|---|---|
Market Cap | $79.86B | $106.24B |
Volume | 1,323,583 | 2,982,001 |
Sector | Industrials | Health |
52-Week High | $216.53 | $388.35 |
52-Week Low | $163.55 | $269.75 |
Typical Hold Time | 125 Days | 21 Days |
Enterprise Value | $82.33B | $117.70B |
Dividend Yield | 1.03% | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cintas (CTAS) trades at $202.25, up 2.57% today, reflecting strong momentum after recent earnings beats. The stock shows bullish technical signals, with price above key moving averages and support at $198. Fundamentally, Q1 2027 revenue reached $3.01 billion, a 10.9% YoY increase, with earnings per share of $1.39 beating estimates. The company raised fiscal 2027 guidance, signaling confidence in continued organic growth and margin expansion, supported by a robust business model in uniform rental and workplace services.
The outlook remains positive given upward earnings revisions and a consensus price target of $234.60, implying 16% upside. However, risks include elevated valuation multiples (P/E 39.67) and sensitivity to economic cycles affecting corporate spending. Analyst sentiment is mixed with 40% buy ratings, but institutional ownership trends and dividend growth underscore long-term stability. Execution on guidance and margin sustainability are key to maintaining premium valuation.
Stryker (SYK) trades at $277.52, up 0.77% today, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279. Fundamentally, the company reported strong profitability with a 14.43% net income margin in 2026 and beat EPS estimates in two of the last three quarters. However, recent news highlights potential legal and manufacturing issues that have pressured investor sentiment.
The outlook is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities lie in SYK's robust earnings growth and market leadership in medical technology, but risks include ongoing legal investigations and persistent manufacturing challenges that could impact future performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cintas Corporation
In its core uniform and facility services unit (78% of sales), Cintas provides uniform rental programs to businesses across the size spectrum, mostly in North America. The firm is by far the largest provider in the industry. Facilities products generally include the rental and sale of entrance mat, mops, shop towels, hand sanitizers, and restroom supplies. Cintas also runs a first aid and safety services business (11% of sales), a fire protection services business (7% of sales), and a uniform direct sales business (4% of sales).
Read more on CTAS →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
